Influenza neuraminidase — Drug Target

All drugs that target Influenza neuraminidase — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Neuraminidase inhibitor

Marketed (7)

• Tamiflu (verum) · National Institute for Public Health and the Environment (RIVM) · Neuraminidase inhibitor · Infectious Disease / Virology
  Tamiflu inhibits neuraminidase, an enzyme on the surface of influenza viruses, preventing viral release from infected cells and reducing viral spread.
• zanamivir for inhalation · University of Oxford · Neuraminidase inhibitor · Infectious Disease
  Zanamivir inhibits neuraminidase, an enzyme on the surface of influenza viruses, preventing viral release from infected cells and blocking spread of infection.
• Oseltamivir Phosphate For Oral Suspension · The Affiliated Hospital of Qingdao University · Neuraminidase inhibitor · Infectious Disease
  Oseltamivir phosphate is a neuraminidase inhibitor that blocks the release of influenza virus particles from infected cells, preventing viral spread.
• Oseltamivir phosphate granules · China Academy of Chinese Medical Sciences · Neuraminidase inhibitor · Infectious Disease / Virology
  Oseltamivir phosphate inhibits viral neuraminidase, preventing the release of influenza virus particles from infected cells and reducing viral spread.
• Tamiflu® · Genuine Research Center, Egypt · Neuraminidase inhibitor · Infectious Disease / Virology
  Tamiflu inhibits viral neuraminidase, preventing influenza virus particles from being released from infected cells.
• active oseltamivir · University of Oxford · Neuraminidase inhibitor · Infectious Disease
  Oseltamivir is a neuraminidase inhibitor that blocks the release of influenza virus particles from infected cells, preventing viral spread.
• Oseltamivir(oral) · Guangdong Raynovent Biotech Co., Ltd · Neuraminidase inhibitor · Infectious Disease
  Oseltamivir is a neuraminidase inhibitor that blocks the release of influenza virus particles from infected cells, reducing viral spread.

Phase 3 pipeline (5)

• CS-8958 · Daiichi Sankyo Co., Ltd. · Neuraminidase inhibitor · Infectious Disease
  CS-8958 is a neuraminidase inhibitor that prevents influenza virus release from infected cells by blocking sialic acid cleavage.
• Placebo to Oseltamivir · Guangdong Raynovent Biotech Co., Ltd · Neuraminidase inhibitor · Infectious Disease / Virology
  This is a Phase 3 clinical trial comparing placebo to oseltamivir (Tamiflu), an antiviral neuraminidase inhibitor used to treat influenza.
• Oseltamivir IV · Hoffmann-La Roche · Neuraminidase inhibitor · Infectious Disease
  Oseltamivir is a neuraminidase inhibitor that blocks the release of influenza virus particles from infected cells, reducing viral spread.
• Five-days oseltamivir · UMC Utrecht · Neuraminidase inhibitor · Infectious Disease
  Oseltamivir is a neuraminidase inhibitor that blocks the release of influenza virus particles from infected cells, reducing viral spread.
• Ten-days oseltamivir · UMC Utrecht · Neuraminidase inhibitor · Infectious Disease
  Oseltamivir is a neuraminidase inhibitor that blocks the release of influenza virus particles from infected cells, reducing viral spread.